Cargando…
Recent advances in developing small-molecule inhibitors against SARS-CoV-2
The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to underst...
Autores principales: | Xiang, Rong, Yu, Zhengsen, Wang, Yang, Wang, Lili, Huo, Shanshan, Li, Yanbai, Liang, Ruiying, Hao, Qinghong, Ying, Tianlei, Gao, Yaning, Yu, Fei, Jiang, Shibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260826/ https://www.ncbi.nlm.nih.gov/pubmed/34249607 http://dx.doi.org/10.1016/j.apsb.2021.06.016 |
Ejemplares similares
-
Development of Small-Molecule Inhibitors Against Zika Virus Infection
por: Wang, Lili, et al.
Publicado: (2019) -
Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
por: Yu, Fei, et al.
Publicado: (2020) -
Development of Small-Molecule MERS-CoV Inhibitors
por: Liang, Ruiying, et al.
Publicado: (2018) -
Influenza virus glycoprotein-reactive human monoclonal antibodies
por: Li, Yanbai, et al.
Publicado: (2020) -
Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
por: Zhang, Qianqian, et al.
Publicado: (2021)